BeOne Medicines Ltd. (NASDAQ:ONC) Q2 2025 Earnings Call Transcript August 6, 2025
Operator: Good day, everyone. Welcome to BeOne Q2 2025 Earnings Call Webcast. [Operator Instructions] At this time, I would like to turn the call over to the company.
Daniel Maller: Hello and welcome. Thanks for joining us today. I’m Dan Miller, Head of Investor Relations at BeOne Medicines. Before we begin, please note that you can find additional materials, including a replay of today’s webcast and...
